iSOFT Signs Sixth LORENZO Site in Germany

iSOFT Group LimitediSOFT Group Limited (ASX: ISF) - Australia's largest listed health information technology company today announced that Christophorus-Kliniken will become the sixth early adopter of iSOFT’s LORENZO next-generation solution in Germany as part of an agreement to upgrade hospital information systems (HIS) at its three hospitals in the Coesfeld district of North Rhine-Westphalia.

The five-year deal potentially is worth as much as €1.43 million (A$2.5 million). The initial two phases, which include the first LORENZO components and an upgrade of iSOFT's ClinicCentre HIS solution, are valued at €675,000 (A$1.2 million) in license fees and services plus €257,000 (A$447,000) in support and maintenance services over five years. An optional third phase, which includes additional LORENZO functionality, is worth a potential €500,000 (A$870,000).

"This is further evidence that our new LORENZO technology is gaining traction with our existing client base in Europe," said Gary Cohen, iSOFT's Executive Chairman & CEO. "It's part of our broader strategy for LORENZO outside of the UK's National Programme for Information Technology."

The first LORENZO elements and iSOFT's Collaboration Suite (iCS) will provide a new electronic patient record (EPR) for GP's to access hospital patient records using standard web browsers. iCS allows the secure exchange of patient information between care providers to improve collaboration between teams.

Christophorus-Kliniken follows Klinikum Saarbrücken, which recently became iSOFT's fifth LORENZO early adopter in Germany. The three Christophorus-Kliniken hospitals covered by the new contract are Coesfeld's St Vincenz Hospital, Franz Hospital at Dülmen and St Gerburgis Hospital at Nottuln, which provide a total of 620 beds and employ 1,500 staff.

Christophorus-Kliniken is an existing client for iSOFT's ClinicCentre and its LabCentre laboratory information system and BusinessCentre finance, administration and management solution.

Other LORENZO early adopters in Germany are Aachen, Leipzig, Krankenhaus Buchholz and Winsen, and Klinikum Saarbrücken.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 38 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,600 specialists in 16 locations worldwide, including more than 2,300 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...